Standout Papers

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoi... 2008 2026 2014 2020 849
  1. IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial (2008)
    Paul Emery, Edward Keystone et al. Annals of the Rheumatic Diseases

Immediate Impact

12 from Science/Nature 96 standout
Sub-graph 1 of 20

Citing Papers

Upadacitinib Induction and Maintenance Therapy for Crohn’s Disease
2023 Standout
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
2023 Standout
9 intermediate papers

Works of Antonio Sánchez being referenced

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial
2008 Standout

Author Peers

Author Last Decade Papers Cites
Antonio Sánchez 83 76 78 666 333 19 975
Agnes L. Maier 50 88 77 624 356 22 1.1k
José Ramón Maneiro 30 86 90 716 228 28 1.0k
J.M. Kremer 84 92 36 538 266 26 780
J. S. Smolen 77 132 68 567 217 23 925
Maria J. H. de Hair 27 78 47 715 188 35 1.1k
H D Boloşiu 23 76 77 897 384 17 1.1k
S M van der Kooij 32 49 30 956 354 17 1.1k
Mitchell B. Lowenstein 23 59 32 718 278 19 1.1k
Christina Dickson 40 88 18 658 269 13 876
Stéphan Pavy 30 134 95 582 184 32 985

All Works

Loading papers...

Rankless by CCL
2026